Pro Medicus Limited (PMCUF) Research

Based in Richmond, Australia, and established in 1983, Pro Medicus Limited is a leading developer and provider of cutting-edge healthcare imaging software and support services. The company caters to a diverse range of medical institutions, including hospitals and diagnostic imaging facilities, across Australia, North America, and Europe. Its comprehensive product suite features a proprietary Radiology Information System (RIS), designed for efficient practice management, which comes complete with training, installation, professional services, and ongoing post-sales support (marketed under names like Visage RIS). Additionally, Pro Medicus offers Promedicus.net, an e-health platform, and advanced healthcare imaging software that empowers radiologists and clinicians with robust visualization capabilities for 2D, 3D, and 4D medical images, alongside its Picture Archiving and Communication System (PACS)/digital imaging solutions (e.g., Visage 7). The company also provides integration products and the Visage Ease Pro mobile application, allowing users to remotely interpret diagnostic imaging studies stored on a Visage 7 server.

Market snapshot

Symbol
PMCUF
Price
$118.13
Day change
-0.82%
Market cap
$18.1B
P/E ratio
76.80x
52-week range
74.52-218.25
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months
Analyst price target
$155

Peer companies

  • Astellas Pharma Inc. (ALPMF)
  • bioMérieux S.A. (BMXXY)
  • Lynx Global Digital Finance Corporation (CNONF)
  • Fresenius Medical Care AG & Co. KGaA (FMCQF)
  • Grifols, S.A. (GIKLY)
  • Innovent Biologics, Inc. (IVBXF)
  • Sartorius AG (SARTF)
  • Smith & Nephew plc (SNNUF)

Open Pro Medicus Limited (PMCUF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.